|Bid||42.36 x 1200|
|Ask||42.37 x 1400|
|Day's Range||41.89 - 42.57|
|52 Week Range||37.07 - 72.96|
|Beta (3Y Monthly)||1.20|
|PE Ratio (TTM)||118.43|
|Earnings Date||Aug 5, 2019 - Aug 9, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.29|
Avanos Medical Inc NYSE:AVNSView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for AVNS with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding AVNS totaled $73 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Avanos Medical, Inc.'s (NYSE:AVNS): Avanos Medical, Inc. operates as a medical technology company that focuses on...
Designation recognizes products that bring improvements to the health care industry ALPHARETTA, Ga. , May 28, 2019 /PRNewswire/ -- Avanos Medical (NYSE: AVNS), a company focused on delivering clinically ...
ALPHARETTA, Ga. , May 9, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") announced today that it commenced a cash tender offer (the "Tender Offer") to purchase up ...
Avanos Medical (AVNS) delivered earnings and revenue surprises of -11.76% and 0.03%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 43 cents. Earnings, adjusted for one-time gains and costs, came to 15 cents per share. The results missed Wall Street expectations. ...
Announces Minority Stake in NeoMed, Inc. ALPHARETTA, Ga. , May 7, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2019 results. "I'm pleased that we have delivered ...
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! How far off is Avanos Medical, Inc. (NYSE:AVNS) from its intrinsic value? Using the most recent finan...
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ALPHARETTA, Ga., April 23, 2019 /PRNewswire/ -- Avanos Medical, Inc. (AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2019 on Tuesday, May 7 at 9 a.m. ET. The conference call will be hosted by Joe Woody, chief executive officer, and Steve Voskuil, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States.
Changes to the current ON-Q* pump bolus device reflect feedback from customers and consumers to increase provider and patient satisfaction ALPHARETTA, Ga. , April 3, 2019 /PRNewswire/ -- Avanos Medical, ...
Nevro Corp. (NVRO) is among a host of public and private companies marketing or developing medical devices to treat pain. Warning! GuruFocus has detected 2 Warning Signs with NVRO. Medical device companies that can help reduce opioid use promise to be rewarded handsomely and merit the attention of savvy investors.
ALPHARETTA, Ga. , March 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody , chief executive officer, will present at the Barclays Global Healthcare Conference on ...
COOLIEF* Cooled RF superior to hyaluronic acid injection in a study of knee osteoarthritis patients. ALPHARETTA, Ga., March 4, 2019 /PRNewswire/ -- Avanos Medical, Inc. (AVNS) today announced that its study comparing COOLIEF* Cooled Radiofrequency to hyaluronic acid (HA) in the management of knee pain achieved its primary endpoint with a statistically significant improvement in knee osteoarthritis patients experiencing at least 50 percent reduction in knee pain at 6 months after treatment (p